247 results
8-K
EX-10.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
include the name of the target (or targets) or a summary description of the assets to be acquired and shall confirm that the aggregate purchase … of any Sanctions, (ii) included on OFAC’s List of Specially Designated Nationals or HMT’s Consolidated List of Financial Sanctions Targets, or any
425
xmle wvyl29
3 Oct 22
Business combination disclosure
9:20am
8-K
EX-99.1
6l47k knstgbf96s
3 Oct 22
Ligand Announces Record Date and Details for Distribution for OmniAb Spin-Off
9:18am
425
bzu6z28qsam1
24 Aug 22
Business combination disclosure
5:21pm
8-K
EX-99.1
lh7 8pcoeal
8 Aug 22
Ligand Reports Second Quarter 2022 Financial Results
4:06pm
425
EX-99.1
urn6dro0pofz
21 Jun 22
Business combination disclosure
8:00am
8-K
EX-99.1
xs3hhyi
21 Jun 22
Regulation FD Disclosure
6:19am
425
kj9ek
5 May 22
Business combination disclosure
7:30am
8-K
EX-99.1
oixvx7ieo3czkz8
4 May 22
Ligand Reports First Quarter 2022 Financial Results
4:03pm
425
ga8xqfb82mbep
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-10.1
1oxo1ew5
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
pfza3 f90n7hgly77h
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
425
EX-99.1
qqs7xwzowlw
23 Mar 22
Business combination disclosure
5:29pm
425
EX-99.2
07g4j73tmboabs
23 Mar 22
Business combination disclosure
5:29pm